Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Population Council initiates phase I study of griffithsin gel for HIV prevention

Oct. 23, 2017

EC approves Symtuza for HIV-1 in adolescents and adults, NDA filed in U.S.

Sep. 26, 2017

Grant supports IBBR's development of multispecific antibody as therapeutic for HIV

Sep. 6, 2017

GlaxoSmithKline, ViiV identify new HIV allosteric integrase inhibitors

Sep. 5, 2017

ViiV Healthcare divulges new HIV maturation inhibitors

Aug. 24, 2017

GlaxoSmithKline identifies novel ingenol derivatives

Aug. 16, 2017

EMERALD study bolsters darunavir, cobicistat, emtricitabine and tenofovir alafenamide fumarate

Aug. 11, 2017

FDA grants priority review to NDA for bictegravir/emtricitabine/tenofovir alafenamide in HIV

Aug. 11, 2017

Mologen announces results from extension phase of TEACH study of lefitolimod in HIV

Aug. 10, 2017

GlaxoSmithKline patents HIV maturation inhibitors

Aug. 9, 2017

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...